59626-2 |
cloBAZam |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
cloBAZam [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
20 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59626-2 |
|
|
|
|
Both |
|
|
|
0 |
cloBAZam Bld-mCnc |
|
|
|
N |
|
Blood; Clarmyl; Clopax; DRUG/TOXICOLOGY; Drugs; Frisium; Level; Mass concentration; Noiafren; Point in time; QNT; Quan; Quant; Quantitative; Random; Sederlona; Urbadan; Urbanol; Urbanyl; WB; Whole blood |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
59627-0 |
cloBAZam |
MCnc |
Bld |
Pt |
Qn |
Confirm |
|
ACTIVE |
cloBAZam [Mass/volume] in Blood by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
20 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59627-0 |
|
Confirm |
|
|
Both |
|
|
|
0 |
cloBAZam Bld Cfm-mCnc |
|
|
|
N |
|
Blood; Cfm; Clarmyl; Clopax; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Frisium; GCMS; LC/MS/MS; Level; Mass concentration; Noiafren; Point in time; QNT; Quan; Quant; Quantitative; Random; Sederlona; Urbadan; Urbanol; Urbanyl; WB; Whole blood |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
59628-8 |
cloBAZam |
MCnc |
Body fld |
Pt |
Qn |
|
|
ACTIVE |
cloBAZam [Mass/volume] in Body fluid |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
20 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59628-8 |
|
|
|
|
Both |
|
|
|
0 |
cloBAZam Fld-mCnc |
|
|
|
N |
|
B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Clarmyl; Clopax; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Frisium; Level; Mass concentration; Noiafren; Point in time; QNT; Quan; Quant; Quantitative; Random; Sederlona; Urbadan; Urbanol; Urbanyl |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
59629-6 |
cloBAZam |
MCnc |
Body fld |
Pt |
Qn |
Confirm |
|
ACTIVE |
cloBAZam [Mass/volume] in Body fluid by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
20 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59629-6 |
|
Confirm |
|
|
Both |
|
|
|
0 |
cloBAZam Fld Cfm-mCnc |
|
|
|
N |
|
B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cfm; Clarmyl; Clopax; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Frisium; GCMS; LC/MS/MS; Level; Mass concentration; Noiafren; Point in time; QNT; Quan; Quant; Quantitative; Random; Sederlona; Urbadan; Urbanol; Urbanyl |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
5963-4 |
Coagulation tissue factor induced.factor substitution^immediately after addition of normal plasma |
Time |
PPP^Control |
Pt |
Qn |
Tilt tube |
|
DEPRECATED |
Deprecated Prothrombin time (PT) factor substitution in Platelet poor plasma from control by Coagulation assay --immediately after addition of normal plasma |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
COAG |
|
5963-4 |
|
Tilt tube |
|
|
|
|
|
|
0 |
Deprecated PT imm NP PPP Cont Qn |
|
|
|
|
|
Coag; Contrl; Control; Fac; Fact; Hematology; Heme; imm NP; Immediatedly after 1:1 addition of; Mixing studies; Normal; Plas; Platelet poor plasma; Point in time; Pro time; Prothrombin time; Protime; PT; PT correction study; PT immediate mix; PT incubated mix; QNT; Quan; Quant; Quantitative; Random |
2.36 |
1.0d |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
59630-4 |
cloBAZam |
MCnt |
Meconium |
Pt |
Qn |
|
|
ACTIVE |
cloBAZam [Mass/mass] in Meconium |
|
MIN |
DefinitionDescription |
|
|
ng/g |
20 ng/g |
|
|
|
|
|
DRUG/TOX |
|
59630-4 |
|
|
|
|
Both |
|
|
|
0 |
cloBAZam Mec-mCnt |
|
|
|
N |
|
Clarmyl; Clopax; DRUG/TOXICOLOGY; Drugs; Frisium; Mass content; Mec; Noiafren; Point in time; QNT; Quan; Quant; Quantitative; Random; Sederlona; Urbadan; Urbanol; Urbanyl |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/g |
|
|
|
0 |
59631-2 |
cloBAZam |
MCnt |
Meconium |
Pt |
Qn |
Confirm |
|
ACTIVE |
cloBAZam [Mass/mass] in Meconium by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/g |
20 ng/g |
|
|
|
|
|
DRUG/TOX |
|
59631-2 |
|
Confirm |
|
|
Both |
|
|
|
0 |
cloBAZam Mec Cfm-mCnt |
|
|
|
N |
|
Cfm; Clarmyl; Clopax; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Frisium; GCMS; LC/MS/MS; Mass content; Mec; Noiafren; Point in time; QNT; Quan; Quant; Quantitative; Random; Sederlona; Urbadan; Urbanol; Urbanyl |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/g |
|
|
|
0 |
59632-0 |
cloBAZam |
MCnc |
Ser/Plas |
Pt |
Qn |
Confirm |
|
ACTIVE |
cloBAZam [Mass/volume] in Serum or Plasma by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
20 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59632-0 |
|
Confirm |
|
|
Both |
|
|
|
0 |
cloBAZam SerPl Cfm-mCnc |
|
|
|
N |
|
Cfm; Clarmyl; Clopax; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Frisium; GCMS; LC/MS/MS; Level; Mass concentration; Noiafren; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Sederlona; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Urbadan; Urbanol; Urbanyl |
2.73 |
2.32 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
59633-8 |
cloBAZam |
MCnt |
Tiss |
Pt |
Qn |
|
|
ACTIVE |
cloBAZam [Mass/mass] in Tissue |
|
MIN |
DefinitionDescription |
|
|
ng/g |
20 ng/g |
|
|
|
|
|
DRUG/TOX |
|
59633-8 |
|
|
|
|
Both |
|
|
|
0 |
cloBAZam Tiss-mCnt |
|
|
|
N |
|
Clarmyl; Clopax; DRUG/TOXICOLOGY; Drugs; Frisium; Mass content; Noiafren; Point in time; QNT; Quan; Quant; Quantitative; Random; Sederlona; Tissue; Tissue, unspecified; Urbadan; Urbanol; Urbanyl |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/g |
|
|
|
0 |
59634-6 |
cloBAZam |
MCnt |
Tiss |
Pt |
Qn |
Confirm |
|
ACTIVE |
cloBAZam [Mass/mass] in Tissue by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/g |
20 ng/g |
|
|
|
|
|
DRUG/TOX |
|
59634-6 |
|
Confirm |
|
|
Both |
|
|
|
0 |
cloBAZam Tiss Cfm-mCnt |
|
|
|
N |
|
Cfm; Clarmyl; Clopax; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Frisium; GCMS; LC/MS/MS; Mass content; Noiafren; Point in time; QNT; Quan; Quant; Quantitative; Random; Sederlona; Tissue; Tissue, unspecified; Urbadan; Urbanol; Urbanyl |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/g |
|
|
|
0 |
59635-3 |
cloBAZam |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
cloBAZam [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
20 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59635-3 |
|
Confirm |
|
|
Both |
|
|
|
0 |
cloBAZam Ur Cfm-mCnc |
|
|
|
N |
|
Cfm; Clarmyl; Clopax; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Frisium; GCMS; LC/MS/MS; Level; Mass concentration; Noiafren; Point in time; QNT; Quan; Quant; Quantitative; Random; Sederlona; UA; UR; Urbadan; Urbanol; Urbanyl; Urn |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
59636-1 |
clonazePAM |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
clonazePAM [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
2 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59636-1 |
|
|
|
|
Both |
|
|
|
0 |
clonazePAM Bld-mCnc |
|
|
|
N |
|
Blood; DRUG/TOXICOLOGY; Drugs; Klonopin; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
59637-9 |
clonazePAM |
MCnc |
Bld |
Pt |
Qn |
Confirm |
|
ACTIVE |
clonazePAM [Mass/volume] in Blood by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
2 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59637-9 |
|
Confirm |
|
|
Both |
|
|
|
0 |
clonazePAM Bld Cfm-mCnc |
|
|
|
N |
|
Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Klonopin; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.73 |
2.32 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
59638-7 |
clonazePAM |
MCnc |
Body fld |
Pt |
Qn |
|
|
ACTIVE |
clonazePAM [Mass/volume] in Body fluid |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
2 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59638-7 |
|
|
|
|
Both |
|
|
|
0 |
clonazePAM Fld-mCnc |
|
|
|
N |
|
B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Klonopin; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
59639-5 |
clonazePAM |
MCnc |
Body fld |
Pt |
Qn |
Confirm |
|
ACTIVE |
clonazePAM [Mass/volume] in Body fluid by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
2 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59639-5 |
|
Confirm |
|
|
Both |
|
|
|
0 |
clonazePAM Fld Cfm-mCnc |
|
|
|
N |
|
B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; GCMS; Klonopin; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
5964-2 |
Coagulation tissue factor induced |
Time |
Bld |
Pt |
Qn |
Coag |
|
ACTIVE |
Prothrombin time (PT) in Blood by Coagulation assay |
|
MIN |
DefinitionDescription |
|
|
s |
|
|
|
|
|
|
COAG |
|
5964-2 |
|
Coag |
|
|
Both |
|
|
|
0 |
PT Bld |
|
|
|
Y |
|
Blood; Clot; Clottable; Coag; Coagulation assay; Fac; Fact; Hematology; Heme; Point in time; Pro time; Prothrombin time; Protime; PT; QNT; Quan; Quant; Quantitative; Random; Tilt tube; WB; Whole blood |
2.73 |
1.0d |
|
|
|
|
|
|
|
s |
|
|
|
0 |
59640-3 |
clonazePAM |
MCnc |
Ser/Plas |
Pt |
Qn |
Confirm |
|
ACTIVE |
clonazePAM [Mass/volume] in Serum or Plasma by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
2 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59640-3 |
|
Confirm |
|
|
Both |
|
|
|
0 |
clonazePAM SerPl Cfm-mCnc |
|
|
|
N |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Klonopin; LC/MS/MS; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.32 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
59641-1 |
clonazePAM |
MCnt |
Tiss |
Pt |
Qn |
|
|
ACTIVE |
clonazePAM [Mass/mass] in Tissue |
|
MIN |
DefinitionDescription |
|
|
ng/g |
2 ng/g |
|
|
|
|
|
DRUG/TOX |
|
59641-1 |
|
|
|
|
Both |
|
|
|
0 |
clonazePAM Tiss-mCnt |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Klonopin; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/g |
|
|
|
0 |
59642-9 |
clonazePAM |
MCnt |
Tiss |
Pt |
Qn |
Confirm |
|
ACTIVE |
clonazePAM [Mass/mass] in Tissue by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/g |
2 ng/g |
|
|
|
|
|
DRUG/TOX |
|
59642-9 |
|
Confirm |
|
|
Both |
|
|
|
0 |
clonazePAM Tiss Cfm-mCnt |
|
|
|
N |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Klonopin; LC/MS/MS; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified |
2.73 |
2.32 |
|
|
|
|
|
|
|
ng/g |
|
|
|
0 |
59643-7 |
Cocaethylene |
MCnc |
Ser/Plas |
Pt |
Qn |
Confirm |
|
ACTIVE |
Cocaethylene [Mass/volume] in Serum or Plasma by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
20 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59643-7 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Cocaethylene SerPl Cfm-mCnc |
|
|
|
N |
|
Cfm; CNFR; CNFRM; Cocaine/Ethanol By-Product; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
59644-5 |
Cocaine |
MCnc |
Ser/Plas |
Pt |
Qn |
Confirm |
|
ACTIVE |
Cocaine [Mass/volume] in Serum or Plasma by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
20 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59644-5 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Cocaine SerPl Cfm-mCnc |
|
|
|
N |
|
Addiction; Benzoylmethylecgonine; Cfm; CNFR; CNFRM; Coke; Conf; Confirmation; Confirmatory; Crack; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecgonine methyl ester benzoate; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Snow; SR |
2.73 |
2.32 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
59645-2 |
Cotinine |
PrThr |
Ser/Plas |
Pt |
Ord |
Screen |
|
ACTIVE |
Cotinine [Presence] in Serum or Plasma by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
5 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59645-2 |
|
Screen |
|
|
Both |
|
|
|
0 |
Cotinine SerPl Ql Scn |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Nicotine metabolite; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.32 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
59646-0 |
Cotinine |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
Cotinine [Presence] in Urine by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
40 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59646-0 |
|
Screen |
|
|
Both |
|
|
|
0 |
Cotinine Ur Ql Scn |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Nicotine metabolite; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn |
2.73 |
2.32 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
59647-8 |
N-desalkylflurazepam |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
N-desalkylflurazepam [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
5 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59647-8 |
|
|
|
|
Both |
|
|
|
0 |
Desalkylfluraz Bld-mCnc |
|
|
|
N |
|
Blood; Desalkyfluraz; Desalkylfluraz; Desalkylflurazepam; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; Level; Mass concentration; norfludiazepam; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
59648-6 |
N-desalkylflurazepam |
MCnc |
Body fld |
Pt |
Qn |
|
|
ACTIVE |
N-desalkylflurazepam [Mass/volume] in Body fluid |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
5 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59648-6 |
|
|
|
|
Both |
|
|
|
0 |
Desalkylfluraz Fld-mCnc |
|
|
|
N |
|
B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Desalkyfluraz; Desalkylfluraz; Desalkylflurazepam; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Flurazepam metabolite; Level; Mass concentration; norfludiazepam; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |